Matches in Wikidata for { <http://www.wikidata.org/entity/Q62787738> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- Q62787738 description "article scientifique publié en 2017" @default.
- Q62787738 description "im Mai 2017 veröffentlichter wissenschaftlicher Artikel" @default.
- Q62787738 description "wetenschappelijk artikel" @default.
- Q62787738 description "наукова стаття, опублікована в травні 2017" @default.
- Q62787738 name "Phase II trial of pembrolizumab in combination with nab-paclitaxel in patients with metastatic HER2-negative breast cancer" @default.
- Q62787738 name "Phase II trial of pembrolizumab in combination with nab-paclitaxel in patients with metastatic HER2-negative breast cancer" @default.
- Q62787738 type Item @default.
- Q62787738 label "Phase II trial of pembrolizumab in combination with nab-paclitaxel in patients with metastatic HER2-negative breast cancer" @default.
- Q62787738 label "Phase II trial of pembrolizumab in combination with nab-paclitaxel in patients with metastatic HER2-negative breast cancer" @default.
- Q62787738 prefLabel "Phase II trial of pembrolizumab in combination with nab-paclitaxel in patients with metastatic HER2-negative breast cancer" @default.
- Q62787738 prefLabel "Phase II trial of pembrolizumab in combination with nab-paclitaxel in patients with metastatic HER2-negative breast cancer" @default.
- Q62787738 P1433 Q62787738-CC0E4264-73E0-46BC-B630-1CACFEE74FC5 @default.
- Q62787738 P1476 Q62787738-F7A4635B-ED8A-4619-AD08-1339A9DF86C9 @default.
- Q62787738 P2093 Q62787738-2AB99F21-E2E5-4A4C-8307-F4D52A806672 @default.
- Q62787738 P2093 Q62787738-33D5F3CF-312A-4BBC-ACE2-DEA5FE93D761 @default.
- Q62787738 P2093 Q62787738-39C43933-1DD6-493E-837A-14E7A2D11A1A @default.
- Q62787738 P2093 Q62787738-6FDF8AD0-60A9-4D38-9B35-92F7B3ADB62D @default.
- Q62787738 P2093 Q62787738-7538017A-D246-4970-AF1D-608629FAB994 @default.
- Q62787738 P2093 Q62787738-7C5F4EAA-E3B9-43A2-9F12-E4ED97E92EA5 @default.
- Q62787738 P2093 Q62787738-804ABE0A-F153-407A-9E5A-5C4193FD8FB6 @default.
- Q62787738 P2093 Q62787738-93B8F369-7937-4303-82A3-E83B14EDA746 @default.
- Q62787738 P2093 Q62787738-A1AA7599-ABA5-45CB-85F4-B06A6966927E @default.
- Q62787738 P2093 Q62787738-A812E736-8733-4C83-B453-EDAD1F13325D @default.
- Q62787738 P2093 Q62787738-B16C9EBE-CF44-4F22-85B4-DF8D5490902E @default.
- Q62787738 P2093 Q62787738-E86AFC12-A90D-4453-8534-651E15454F34 @default.
- Q62787738 P304 Q62787738-10DED7E0-7794-4ACE-964C-AC009B0B56E6 @default.
- Q62787738 P31 Q62787738-0E115A79-8395-449B-8BD2-F49F60787DBE @default.
- Q62787738 P356 Q62787738-DD8B67C3-4AE4-4C97-B456-9CFD053D3CED @default.
- Q62787738 P407 Q62787738-7BFE0CAA-AC65-4469-B66E-E1B941AF5AEF @default.
- Q62787738 P433 Q62787738-B88D2600-7A10-435C-8B1C-343F5F3B7436 @default.
- Q62787738 P478 Q62787738-83084C4E-5591-4245-996C-56917761606C @default.
- Q62787738 P50 Q62787738-FAF0B068-007C-42D4-BBDC-097099AB3E92 @default.
- Q62787738 P577 Q62787738-0897BF5D-EF8B-4902-BE00-AED9710368E5 @default.
- Q62787738 P921 Q62787738-7035460F-208F-4CA1-B429-F016927E7B8D @default.
- Q62787738 P921 Q62787738-98C73501-61E6-4EE7-B833-537B246FF4DD @default.
- Q62787738 P356 JCO.2017.35.15_SUPPL.TPS1124 @default.
- Q62787738 P1433 Q400292 @default.
- Q62787738 P1476 "Phase II trial of pembrolizumab in combination with nab-paclitaxel in patients with metastatic HER2-negative breast cancer" @default.
- Q62787738 P2093 "Alyssa Iwano" @default.
- Q62787738 P2093 "Deborah M. Axelrod" @default.
- Q62787738 P2093 "Francisco J. Esteva" @default.
- Q62787738 P2093 "James L. Speyer" @default.
- Q62787738 P2093 "Judith D. Goldberg" @default.
- Q62787738 P2093 "Marleen Iva Meyers" @default.
- Q62787738 P2093 "Maryann J. Kwa" @default.
- Q62787738 P2093 "Rebecca Hogan" @default.
- Q62787738 P2093 "Ruth Oratz" @default.
- Q62787738 P2093 "Sandra Mendoza" @default.
- Q62787738 P2093 "Sylvia Adams" @default.
- Q62787738 P2093 "Yelena Novik" @default.
- Q62787738 P304 "TPS1124-TPS1124" @default.
- Q62787738 P31 Q13442814 @default.
- Q62787738 P356 "10.1200/JCO.2017.35.15_SUPPL.TPS1124" @default.
- Q62787738 P407 Q1860 @default.
- Q62787738 P433 "15_suppl" @default.
- Q62787738 P478 "35" @default.
- Q62787738 P50 Q30512486 @default.
- Q62787738 P577 "2017-05-20T00:00:00Z" @default.
- Q62787738 P921 Q13896859 @default.
- Q62787738 P921 Q42824440 @default.